CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
Schall, Brown & Schwartz LLP issued a shareholder-solicitation notice regarding Capricor Therapeutics, alleging securities fraud related to its Deramiocel BLA submission. The release is a routine lead-plaintiff-deadline reminder for a class period of December 17, 2025 to July 26, 2026, encouraging investors to contact the firm.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.